In summary, hepatocyte death, inflammation, and liver fibrosis in middle-aged A/AHep mice deficient in hepatic eIF2α phosphorylation were aggravated by an HFrD; thus eIF2α phosphorylation in hepatocytes opposes the deleterious effects of an HFrD treatment. Here, EIF2A is linked to Hepatic fibrosis.